Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Viral Immunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1558604

This article is part of the Research Topic Animal-borne viral disease: Pathogenesis, Innate immunity, Acquired immunity, and Novel vaccine development View all 8 articles

Establishment of a Pseudovirus neutralization assay for TGEV

Provisionally accepted
Haojie Wang Haojie Wang Haojie Wang Haojie Wang 1Jianxing Chen Jianxing Chen 1Lihong Xue Lihong Xue 1Yue Sun Yue Sun 1Tongqing An Tongqing An 1Yue Wang Yue Wang 1Hongyan Chen Hongyan Chen 1Changqing Yu Changqing Yu 2Changyou Xia Changyou Xia 1He Zhang He Zhang 1*
  • 1 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, Heilongjiang Province, China
  • 2 Yibin Vocational and Technical College, Yibin, Sichuan Province, China

The final, formatted version of the article will be published soon.

    Introduction: Transmissible Gastroenteritis Virus (TGEV) is a major pathogen causing swine enteric diseases, necessitating effective control strategies. Vaccination plays a key role, but assessing vaccine efficacy remains challenging due to variations in immune response and existing detection limitations. Current antibody detection methods, such as neutralization assays and ELISA, are often subjective, labor-intensive, and time-consuming, highlighting the need for a more efficient evaluation approach. Methods and results: The TGEV S gene was amplified and inserted into the eukaryotic vector PM2.G-ΔG-HA to construct the recombinant plasmid PM2.G-ΔG-TGEV-S-HA. Transfecting ST cells with this plasmid, followed by infection with G*VSV-GFP/LUC, successfully produced TGEV P0 pseudoviruses. Western blot and electron microscopy confirmed the presence of TGEV S and VSV N proteins and the distinct pseudovirus morphology. Optimization determined that 0.5 μg/well of plasmid, 24 h transfection, and 24 h post-infection harvest yielded a viral titer of 10⁶-10⁷ TCID₅₀/mL. The pseudoviruses exhibited strong ST cell tropism and were effectively neutralized by TGEV-positive sera. A pseudovirus-based neutralization test (pNT) was established, showing 100% sensitivity, 96.6% specificity, no cross-reactivity with PEDV, PPV, PDCoV, or PRoV, and a 94% concordance with the live virus neutralization test. The method effectively tracked antibody level changes post-TGEV vaccination. Discussion: This study successfully developed a novel pseudovirus-based detection method, overcoming traditional assay limitations.The pNT method provides a scalable, efficient, and reliable tool for TGEV antibody evaluation, with broad potential applications in pathogen detection and vaccine assessment.

    Keywords: TGEV, Pseudovirus, neutralizing antibody, pseudovirus neutralization test, ST cells

    Received: 10 Jan 2025; Accepted: 24 Mar 2025.

    Copyright: © 2025 Haojie Wang, Chen, Xue, Sun, An, Wang, Chen, Yu, Xia and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: He Zhang, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, 150069, Heilongjiang Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more